TROG Ambassador Program is an initiative aimed at engaging passionate individuals to champion our mission of improving treatment and outcomes for those affected by cancer. Though this program, we are inviting people from diverse backgrounds to join us as volunteers in raising awareness, inspiring action, and fostering community support for our groundbreaking cancer clinical trials and research.
The TROG Ambassador Program is designed to bring together survivors, advocates, healthcare professionals, researchers, media personalities, and community leaders who share a common goal: to make a meaningful impact in the fight against cancer.
As an Ambassador, you will have the opportunity to:
We are seeking individuals with the following qualities, who are looking to take on a voluntary role:
Contribute to advancing cancer research and improving lives as part of a united community.
Gain recognition as a champion of a globally respected organisation.
Network with leading professionals in oncology, research, and healthcare.
Experience the profound satisfaction of driving meaningful change in the fight against cancer.
Inspire others to join in the collective effort toward better cancer care.
Join us in our mission to transform cancer treatment through innovation, collaboration, and advocacy. Together, we can make a lasting impact in the fight against cancer.
To express your interest in becoming a TROG Ambassador, please complete the Expression of Interest form
Applications will be reviewed by the TROG Executive team based on alignment with our mission and the potential to make a meaningful impact. All applicants will be contacted in due course regarding the outcome of their application.
Closing date for initial applications: Wednesday 30 April 2025. Applications outside of the application deadline will be considered on a case-by-case basis.
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Latest News
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292